FDA notes Paratek antibiotic’s noninferiority as it heads to AdComm vote Paratek Pharmaceuticals’ first drug, and the first in a new class of broad-spectrum antibiotics called aminomethylcyclines, has shown to […]
Akouos raises M to take hearing loss gene therapy into humans Akouos has raised $50 million to take a gene therapy treatment for hearing loss into the clinic. The Boston-based […]
Ironwood abandons deal with AstraZeneca for lesinurad, once hoped to be a gout blockbuster Ironwood Pharmaceuticals has decided to walk away from its 2016 deal to license AstraZeneca’s billion-dollar gout […]
Ironwood dumps AstraZeneca gout drug Zurampic—and lays off 125 in the process Zurampic, a drug AstraZeneca once laid out more than $1 billion to get its hands on, has wound […]
Acorda inks Ampyra generic settlements as it waits for patent appeal news Late last month, a court refused to block copies of Acorda’s Ampyra leading up to a patent appeal […]